Imperva Inc. (NYSE:IMPV) insider Amichai Shulman sold 938 shares of Imperva stock in a transaction that occurred on Monday, October 3rd. The shares were sold at an average price of $53.27, for a total transaction of $49,967.26. Following the completion of the transaction, the insider now directly owns 95,085 shares in the company, valued at approximately $5,065,177.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Amichai Shulman also recently made the following trade(s):

  • On Friday, September 23rd, Amichai Shulman sold 937 shares of Imperva stock. The shares were sold at an average price of $51.00, for a total transaction of $47,787.00.
  • On Thursday, September 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $44.30, for a total transaction of $136,665.50.
  • On Monday, August 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $46.87, for a total transaction of $144,593.95.
  • On Wednesday, July 27th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $46.28, for a total transaction of $142,773.80.

Imperva Inc. (NYSE:IMPV) opened at 53.56 on Wednesday. Imperva Inc. has a 12-month low of $31.11 and a 12-month high of $77.99. The firm’s market capitalization is $1.75 billion. The firm has a 50 day moving average of $47.36 and a 200 day moving average of $44.55.

Imperva (NYSE:IMPV) last issued its quarterly earnings results on Thursday, August 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.04) by $0.19. The business had revenue of $57.87 million for the quarter, compared to the consensus estimate of $66.06 million. Imperva had a negative net margin of 23.75% and a negative return on equity of 25.68%. The business’s revenue was up 8.2% compared to the same quarter last year. During the same quarter last year, the business posted ($0.08) EPS. On average, analysts forecast that Imperva Inc. will post ($0.80) EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

A number of brokerages have weighed in on IMPV. BTIG Research lowered shares of Imperva from a “buy” rating to a “neutral” rating in a research note on Monday. Buckingham Research lowered shares of Imperva from a “buy” rating to a “neutral” rating in a research note on Thursday, September 29th. Nomura downgraded shares of Imperva from a “buy” rating to a “neutral” rating and set a $50.00 price objective on the stock. in a report on Monday, September 26th. JMP Securities reiterated an “outperform” rating and issued a $56.00 price objective (up from $50.00) on shares of Imperva in a report on Sunday, September 25th. Finally, Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $60.00 price objective on shares of Imperva in a report on Friday, September 23rd. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $53.33.

Hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Imperva by 8.7% in the second quarter. Vanguard Group Inc. now owns 2,077,265 shares of the company’s stock worth $89,343,000 after buying an additional 165,851 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Imperva by 3.9% in the second quarter. JPMorgan Chase & Co. now owns 1,536,698 shares of the company’s stock worth $66,092,000 after buying an additional 57,686 shares during the last quarter. Credit Suisse AG increased its stake in Imperva by 865.9% in the second quarter. Credit Suisse AG now owns 1,431,447 shares of the company’s stock worth $61,568,000 after buying an additional 1,283,243 shares during the last quarter. Eagle Asset Management Inc. increased its stake in Imperva by 3.1% in the second quarter. Eagle Asset Management Inc. now owns 1,338,055 shares of the company’s stock worth $57,549,000 after buying an additional 40,709 shares during the last quarter. Finally, Pictet Asset Management Ltd. increased its stake in Imperva by 50.6% in the second quarter. Pictet Asset Management Ltd. now owns 804,552 shares of the company’s stock worth $30,718,000 after buying an additional 270,312 shares during the last quarter. Institutional investors own 93.26% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.

5 Day Chart for NYSE:IMPV

Receive News & Stock Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related stocks with our FREE daily email newsletter.